Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RWT
12576
CALL
Redwood Trust
RWT
$604M
| $39.8K | ﹤0.01% |
6,100
-22,600
| -79% | -$163K |
|
12577
Wave Life Sciences
WVE
$1.07B
| $39.8K | ﹤0.01% |
3,218
-934,368
| -100% | -$12.5M |
|
12578
Inovio Pharmaceuticals
INO
$113M
| $39.8K | ﹤0.01% |
+21,728
| New | +$96.2K |
|
12579
CALL
Ultrapar
UGP
$6.56B
| $39.7K | ﹤0.01% |
15,100
+10,600
| +236% | +$35.1K |
|
12580
PUT
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $39.7K | ﹤0.01% |
600
-1,600
| -73% | -$111K |
|
12581
CALL
First Internet Bancorp
INBK
$254M
| $39.6K | ﹤0.01% |
1,100
-3,600
| -77% | -$137K |
|
12582
CEMIG Ordinary Shares
CIG.C
$8.12B
| $39.6K | ﹤0.01% |
+17,058
| New | +$42.1K |
|
|
KNDI
12583
CALL
Kandi Technologies Group
KNDI
$63M
| $39.5K | ﹤0.01% |
32,900
+6,300
| +24% | +$8.2K |
|
|
ADAM
12584
PUT
Adamas Trust
ADAM
$910M
| $39.4K | ﹤0.01% |
6,500
+1,700
| +35% | +$9.99K |
|
12585
CALL
John Wiley & Sons Class A
WLY
$2.61B
| $39.3K | ﹤0.01% |
900
-7,800
| -90% | -$383K |
|
12586
Willamette Valley Vineyards
WVVI
$11.5M
| $39.3K | ﹤0.01% |
+11,726
| New | +$39.7K |
|
12587
PUT
Ivanhoe Electric
IE
$1.66B
| $39.3K | ﹤0.01% |
5,200
-8,600
| -62% | -$79.5K |
|
12588
PUT
StoneX
SNEX
$8.09B
| $39.2K | ﹤0.01% |
+1,350
| New | +$37.8K |
|
12589
PUT
Blend Labs
BLND
$352M
| $39.2K | ﹤0.01% |
9,300
-15,600
| -63% | -$67.1K |
|
12590
CALL
American Well
AMWL
$212M
| $39.1K | ﹤0.01% |
+5,400
| New | +$48.9K |
|
|
RDNW
12591
CALL
RideNow Group
RDNW
$248M
| $39.1K | ﹤0.01% |
7,200
-10,500
| -59% | -$58.2K |
|
|
QQQH
12592
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $39.1K | ﹤0.01% |
750
-350
| -32% | -$18.2K |
|
12593
CALL
Xencor
XNCR
$1.74B
| $39.1K | ﹤0.01% |
1,700
-800
| -32% | -$18.4K |
|
|
ADAM
12594
Adamas Trust
ADAM
$910M
| $39K | ﹤0.01% |
6,437
-29,485
| -82% | -$173K |
|
12595
PUT
Interface
TILE
$2.19B
| $39K | ﹤0.01% |
1,600
+500
| +45% | +$11.5K |
|
|
VSTA
12596
DELISTED
Vasta Platform
VSTA
| $38.9K | ﹤0.01% |
19,448
-2,906
| -13% | -$7.12K |
|
12597
PUT
Orion Group Holdings
ORN
$402M
| $38.8K | ﹤0.01% |
5,300
+5,200
| +5,200% | +$37.6K |
|
12598
Sabre
SABR
$900M
| $38.8K | ﹤0.01% |
10,637
-1,457,378
| -99% | -$5.34M |
|
12599
CALL
Neuronetics
STIM
$230M
| $38.8K | ﹤0.01% |
24,100
-6,000
| -20% | -$6.24K |
|
12600
CNS Pharmaceuticals
CNSP
$8.07M
| $38.8K | ﹤0.01% |
+536
| New | +$38.1K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.